Psoriatic Arthritis Treatment Market 2020 Global Industry Trends, Size, Share Analysis Report. According to this report Global Psoriatic Arthritis Treatment Market will rise from Covid-19 crisis at moderate growth rate during 2020 to 2026. Psoriatic Arthritis Treatment Market includes comprehensive information derived from depth study on Psoriatic Arthritis Treatment Industry historical and forecast market data. Global Psoriatic Arthritis Treatment Market Size To Expand moderately as the new developments in Psoriatic Arthritis Treatment and Impact of COVID19 over the forecast period 2020 to 2026.
Psoriatic Arthritis Treatment Market report provides depth analysis of the market impact and new opportunities created by the COVID19/CORONA Virus pandemic. Report covers Psoriatic Arthritis Treatment Market report is helpful for strategists, marketers and senior management, And Key Players in Psoriatic Arthritis Treatment Industry.
Get Sample Report To Know How COVID-19 Impacting Psoriatic Arthritis Treatment Market
Global Psoriatic Arthritis Treatment Market Insights:
Report Analyzes Global Psoriatic Arthritis Treatment Market Growth Size, Share And Trends By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies) and Regional Forecast, 2019 – 2026.
Some of the companies operating the industry are: AbbVie Inc., Merck & Co., Inc., UCB S.A., Novartis AG, Celgene Corporation, Johnson & Johnson Services, Inc., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Eli Lilly and Company, LEO Pharma A/S, Amgen Inc
The report classifies the global Psoriatic Arthritis Treatment Market on the bases of drug class, route of administration, distribution channel, and geography. By drug class, the global market is grouped into Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Non-steroidal Anti-inflammatory Drugs (NSAIDS), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), and others. Amongst these, the Biologic Disease Modifying Anti-Rheumatic Drugs segment had gained 63.4% global Psoriatic Arthritis Treatment Market share in the year 2018. Fortune Business Insights predicts that the segment will remain in the dominant position throughout the forecast period owing to the rising adoption of biological therapies. This is because such therapies are very efficient in managing psoriatic arthritis. By route of administration, the market is divided into parenteral, oral, and topical. The parenteral route of administration is anticipated to procure major share of the global Psoriatic Arthritis Treatment Market. This is because most of the biological products are only provided by parenteral route.
Major Market Players, such as AbbVie Inc. and Pfizer Inc. Focus on Achieving Drug Approvals to Gain Competitive Edge
AbbVie Inc., a publicly traded biopharmaceutical company, based in the U.S., announced in March 2019 that the Japanese Ministry of Health, Labor and Welfare (MHLW) approved its product called SKYRIZI (risankizumab). SKYRIZI is an interleukin-23 (IL-23) inhibitor that is used for the treatment of erythrodermic psoriasis, plaque psoriasis, psoriatic arthritis, and generalized pustular psoriasis in those adults who have difficulties in having an inadequate response to conventional therapies. SKYRIZI also causes improvements in the signs and symptoms of immune-mediated and chronic diseases.
Novartis AG, a multinational pharmaceutical company headquartered in Switzerland, announced that the company has received the approval of European Commission (EC) for Cosentyx label update in Europe in October 2018. Cosentyx is the only fully-human treatment that inhibits interleukin-17A (IL-17A) in psoriatic arthritis. The new update offers a dosing flexibility of up to 300 mg that will aid clinicians in choosing the best dose for their patients.
Regional Market Overview:
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2024, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
Intended Audience:
- Psoriatic Arthritis Treatment Key Players
- Psoriatic Arthritis Treatment Suppliers
- Research and Development (RandD) Companies
- Distributer and Supplier companies
- End Users
- Consultants and Investment bankers
- Government as well as Independent Regulatory Authorities
Competitive Analysis:
The Psoriatic Arthritis Treatment Market report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.
Report Highlights:
In-depth information about the latest Psoriatic Arthritis Treatment Industry trends, opportunities, and challenges.
Extensive analysis of the growth drivers And barriers.
Competitive landscape consisting of investments, agreements, contracts, novel product launches, strategic collaborations, and mergers and acquisitions.
List of the segments and the niche areas.
Comprehensive details about the strategies that are being adopted by key players.
Table of Content:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
- Key Insights
4.1. Prevalence of Key Indications, 2017 (Key Countries)
4.2. Economic (Key Countries)
4.3. Key Mergers and Acquisitions
4.4. Pricing Analysis, Key Players, 2017
4.5. Overview: New Developments in Psoriatic Arthritis Treatment
- Global Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2014-2025
5.1. Key Findings / Summary
Continue…
Related News:
Cardiovascular Drugs Market Trends
Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market Trends
Hospital Architecture Market Trends
Granulomatosis With Polyangiitis Treatment Market Trends
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
